National Eye Care Week encourages retina checks

Article

Optos claims the National Eye Care Week is the perfect opportunity to encourage patients to undergo retinal checks.

Optos claims the National Eye Care Week is the perfect opportunity to encourage patients to undergo retinal checks.

The company are encouraging patients to undergo full eye examinations, including a thorough retinal check. Investigating the retina enables the earlier detection of eye conditions such as glaucoma, retinal tears and retinal detachment. The examination can also help to detect non-eye diseases including heart disease, high blood pressure and diabetes.

Dr Brian Tompkins, optometrist, said, "By having the ability to capture so much of the retina and view the results almost immediately, retinal imaging technology acts as a preventive measure. With regular monitoring, scans not only provide clues about a patient’s health, but the images can be easily saved and compared over the years."

Roy Davies, CEO of Optos, commented, "We are using National Eye Care Week as an opportunity to encourage people to make an eye appointment. Eye exams are more than just checking the need for glasses and contact lenses - they are also about checking the health of the inside of our eyes and our body. The eye is the only place where, without surgery, it’s possible to look in and see blood vessels, arteries and a cranial nerve so it’s vital to have regular eye exams that include a comprehensive retina check.”

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.